Buck Wealth Strategies, LLC Novo Nordisk A S Transaction History

Buck Wealth Strategies, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$122.71 - $146.91 $293,645 - $351,555	2,393 New	2,393 $341,000
Q4 2023 Jan 23, 2024	BUY	$87.78 - $105.45 $82,425 - $99,017	939 Added 78.51%	2,135 $220,000
Q3 2023 Nov 06, 2023	BUY	$90.94 - $199.54 $54,382 - $119,324	598 Added 100.0%	1,196 $108,000
Q2 2023 Nov 06, 2023	BUY	$155.98 - $172.65 $779 - $863	5 Added 0.84%	598 $96.8 Million
Q1 2023 Nov 06, 2023	BUY	$132.34 - $159.14 $78,477 - $94,370	593 New	593 $94.4 Million

1,957

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $197B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Buck Wealth Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Buck Wealth Strategies, LLC with notifications on news.